Umbilical Cord Stem Cell Therapy in California
A minimally invasive, outpatient regenerative procedure using ethically donated umbilical cord tissue, available at R3 Stem Cell California provider locations across Northern and Southern California. Your first consultation is always FREE.
WHAT IS UMBILICAL CORD STEM CELL THERAPY?
Umbilical cord stem cell therapy is a minimally invasive, outpatient regenerative procedure that uses processed tissue derived from donated umbilical cord and Wharton’s jelly — obtained ethically from consenting mothers during planned, healthy cesarean deliveries. This tissue is a concentrated source of mesenchymal stem cells (MSCs), growth factors, hyaluronic acid, and signaling proteins that may support the body’s natural tissue repair process.
Unlike PRP or bone marrow procedures, umbilical cord therapy does not use material from the patient’s own body — it is an allograft. The tissue is considered immunologically favorable, meaning reports of rejection are uncommon, though individual response can vary. The procedure is nonsteroidal and does not require general anesthesia. At R3 Stem Cell California, it is one of several regenerative procedures offered to patients across the state.
Note on experimental status: Umbilical cord stem cell therapy for orthopedic and musculoskeletal conditions is considered investigational by the FDA and is not FDA-approved for these indications. The tissue products used are regulated under FDA tissue bank guidelines (21 CFR Part 1271). R3 Stem Cell California discloses this to every patient as part of the consultation process.
Top 5 Benefits of Umbilical Cord Stem Cell Therapy for Arthritis
Umbilical cord tissue is considered one of the richest available sources of mesenchymal stem cells, and interest in this therapy has grown quickly among patients looking for options beyond cortisone injections or surgery. Below are five reasons this therapy draws attention from arthritis patients specifically.
Rich Concentration of Mesenchymal Stem Cells
Umbilical cord tissue is collected from newly delivered, healthy donors, so the mesenchymal stem cells it contains have not been exposed to the aging or environmental wear that reduces cell potency in adult-derived tissue.
Reduces Inflammation
Umbilical cord-derived tissue contains natural anti-inflammatory signaling proteins. This may help calm the joint inflammation associated with degenerative and rheumatoid arthritis, easing symptoms enough for patients to pursue physical therapy and other conservative care.
Supports Cartilage and Joint Tissue Repair
The growth factors present in umbilical cord tissue are associated with tissue remodeling and repair. Researchers believe this may help support cartilage health and slow the degradation commonly seen in arthritic joints, though individual outcomes vary.
Contains Natural Hyaluronic Acid
Umbilical cord tissue naturally contains hyaluronic acid — the same lubricating compound your joints rely on for smooth movement. Delivering it directly to an arthritic joint may help support joint mobility alongside the regenerative effect.
Longer-Acting Regenerative Potential
Because umbilical cord therapy works directly on the affected joint and introduces a concentrated cell and growth factor source, its effects are generally described as building progressively over weeks to months, rather than offering only short-term symptom masking.
CONDITIONS WE ADDRESS
Patients across California come to R3 Stem Cell California with a wide range of musculoskeletal and orthopedic concerns. During your consultation, your provider can discuss whether umbilical cord stem cell therapy is appropriate for your specific situation. Commonly discussed conditions include:
- Knee arthritis and cartilage wear
- Hip joint pain and stiffness
- Shoulder pain and rotator cuff conditions
- Lower back and lumbar spine discomfort
- Cervical (neck) stiffness and pain
- Tennis elbow and golfer's elbow
- Achilles tendon and plantar fascia concerns
- Ligament sprains and tendonitis
- Bursitis (hip, shoulder, knee)
- SI joint inflammation and facet syndrome
- Spinal arthritis
- Wrist, hand, ankle, and foot joint pain
Not Sure If Umbilical Cord Stem Cell Therapy Is Right for You?
That is exactly what the free consultation is for. Your R3 Stem Cell California provider will review your condition, answer your questions honestly, and give you a clear recommendation — with no obligation to proceed.
FREQUENTLY ASKED QUESTIONS
At R3 Stem Cell California, umbilical cord stem cell therapy is used for musculoskeletal and orthopedic conditions including joint arthritis (knee, hip, shoulder), tendonitis, ligament sprains, bursitis, cartilage defects, spinal arthritis, SI joint inflammation, and soft tissue injuries. Your provider will confirm whether your specific condition is a candidate during your free consultation.
The tissue used is sourced from umbilical cord and Wharton's jelly tissue donated by consenting mothers during planned, healthy cesarean deliveries. No harm comes to the mother or baby, and no embryos are used. The tissue is processed and screened according to FDA tissue bank regulations before use.
No. Umbilical cord stem cell therapy uses tissue collected from the umbilical cord after a healthy birth — not embryos. It does not involve embryonic stem cells and carries none of the ethical concerns associated with embryonic research.
They are related but not identical. Both are donor (allograft) tissues obtained ethically during cesarean deliveries, and both are used to support musculoskeletal repair. Amniotic therapy uses tissue from the amniotic membrane, while umbilical cord therapy uses tissue from the cord itself and Wharton's jelly, which is considered a particularly concentrated source of mesenchymal stem cells. Your provider can explain which is better suited to your condition.
Umbilical cord stem cell therapy for orthopedic and musculoskeletal conditions is considered investigational by the FDA and is not FDA-approved for these indications. R3 Stem Cell California discloses this clearly before any procedure is recommended or scheduled. The tissue products used are regulated under FDA tissue bank guidelines (21 CFR Part 1271).
PRP and bone marrow procedures use material drawn from the patient's own body (autologous). Umbilical cord therapy uses donated allograft tissue instead. All are minimally invasive and outpatient, but the source material and processing differ. Your R3 Stem Cell California provider will explain which option is most appropriate for your condition.
Candidates are typically patients with joint arthritis, tendon or ligament injuries, cartilage wear, or soft tissue conditions seeking a non-surgical, nonsteroidal alternative. Patients who are not surgical candidates, want to explore options before surgery, or have not responded adequately to cortisone or other conservative treatments are often evaluated for this procedure. Suitability is determined at the consultation, not assumed in advance.
Umbilical cord stem cell therapy is an outpatient procedure. Most visits, from preparation through injection, take approximately 30 to 60 minutes. Patients do not require general anesthesia and typically return to light daily activity the same day or the following day.
R3 Stem Cell California has affiliated provider locations across both Northern and Southern California, including cities in the Bay Area, Sacramento region, Orange County, and San Diego. Call (844) GET-STEM or use the contact form on this site to find the nearest provider and schedule a free consultation.
Cost varies depending on the area being treated, the volume of product used, and the specific provider location. Most regenerative procedures, including umbilical cord therapy, are not covered by insurance and are an out-of-pocket expense. R3 Stem Cell California offers financing options and provides transparent cost information at the consultation with no obligation to proceed.
R3 Stem Cell is the only US company to have achieved Institutional Review Board (IRB) approval for investigating regenerative therapies with amniotic and umbilical cord tissue across multiple condition categories. This research is registered publicly on ClinicalTrials.gov. While results vary and the therapy remains investigational, the R3 network brings a depth of real-world clinical experience — tens of thousands of procedures globally — that few regenerative medicine providers can match.
Take the First Step, It Costs Nothing
The free consultation at R3 Stem Cell California is not a sales call. It is a clinical conversation with a qualified provider who will give you honest information about whether umbilical cord stem cell therapy makes sense for your situation, what the procedure involves, and what it realistically may or may not do.